<DOC>
	<DOCNO>NCT01286870</DOCNO>
	<brief_summary>While Core Becker patient follow-up complete Continued Access Study design enroll patient limited rate per month allow continue physician patient experience device . Up 12 patient per month site across United States enrol research study . These patient implant Becker 25 Becker 50 Expander/Breast implant monitor 10 year safety .</brief_summary>
	<brief_title>Becker Continued Access Study</brief_title>
	<detailed_description>Silicone gel-filled breast implant introduce early sixty wide-scale distribution time Medical Device Amendments Food Drug Cosmetic Act pass 1976 . In 1983 , gel-filled breast implant designate Class III device require premarket approval . In May 1990 , Food Drug Administration ( FDA ) publish propose request ( 515 ( b ) ) Pre-market Approval Applications ( PMA ) April 1991 publish final request . This final publication put manufacturer gel-filled breast implant notice continue market gel-filled breast implant , PMA due FDA 90 day final publication date . A pre-market approval ( PMA ) Mentor gel-filled breast implant file FDA July 1991 . At FDA General Plastic Surgery Advisory Committee meet November 1991 , committee recommend submission additional information establish safety effectiveness gel-filled breast implant . In January 1992 , FDA Commissioner announce voluntary moratorium sale gel-filled breast implant allow advisory panel time assess additional information . In April 1992 , moratorium lift reconstruction revision subject . Every subject implant part adjunct study , addition offer participation registry gel-filled breast implant subject . In order implant gel-filled implant augmentation , woman enrol IDE clinical trial . A PMA Mentor 's MemoryGelâ„¢ Silicone Gel-Filled breast implant ( include Becker Expander/Breast Implants ) subsequently file FDA December 2003 , approve November 2006 ( P030053 ) . As condition approval P030053 , new enrollment Mentor 's Adjunct Study cease , woman long access Becker Expander/Breast Implants . The Mentor Becker Expander/Breast Implant use throughout United States time ( since 1992 ) Mentor Adjunct Study allow continue access device collect safety information , however evaluate MemoryGel Core Study . The gel fill use MemoryGel implant gel fill use Becker device . This protocol describe study design procedures population Continued Access ( CA ) Study Mentor Becker 25 50 Expander/Breast implant . While Core Becker patient follow-up complete , CA Study design enroll patient limited rate per month allow continued physician experience device . The safety data obtain may use provide supplemental information PMA . It request study initiate renew every six month final decision reach regard Becker PMA .</detailed_description>
	<criteria>Subject genetic female , 18 year age old A candidate primary breast reconstruction cancer , trauma , surgical loss breast tissue due mastectomy , malignancy , contralateral postreconstruction symmetry , congenital deformity , include asymmetry ( see Section 6.0 definition ) Signs Informed Consent Agrees return device Mentor explant necessary Agrees comply followup procedure , include return followup visit Patient US citizen Social Security Number understand English Subject pregnant Has nurse child within three month study enrollment . Been implant silicone implant include breast implant ( e.g . silicone artificial joint facial implant ) Confirmed diagnosis follow rheumatic disease syndrome : SLE , Sjogren 's syndrome , scleroderma , polymyositis , connective tissue disorder , rheumatoid arthritis , crystalline arthritis , infectious arthritis , spondylarthropathies , inflammatory arthritis , fibromyalgia , chronic fatigue syndrome Infection abscess anywhere body Demonstrates tissue characteristic clinically incompatible implant ( e.g . tissue damage result radiation , inadequate tissue , compromise vascularity ) Possesses condition , treatment condition , opinion investigator and/or consult physician ( ) , may constitute unwarranted surgical risk Anatomic physiologic abnormality could lead significant postoperative adverse event Demonstrates characteristic unrealistic/unreasonable risk involve surgical procedure Premalignant breast disease without subcutaneous mastectomy Untreated inappropriately treat breast malignancy , without mastectomy Are HIV positive Implanted metal metal device , history claustrophobia condition would make MRI scan prohibitive Physician intending use device tissue expansion</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Primary Breast Reconstruction</keyword>
</DOC>